RAYMOND JAMES TRUST N.A. - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES TRUST N.A. ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$36,000
+28.6%
13,1580.0%0.00%0.0%
Q1 2020$28,000
-61.1%
13,1580.0%0.00%
-33.3%
Q4 2019$72,000
+80.0%
13,1580.0%0.00%
+50.0%
Q3 2019$40,000
-18.4%
13,1580.0%0.00%
-33.3%
Q2 2019$49,000
-7.5%
13,1580.0%0.00%0.0%
Q1 2019$53,00013,1580.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,746,0001.82%
Telemetry Investments, L.L.C. 263,975$705,0000.97%
CHI Advisors LLC 719,132$1,920,0000.45%
BVF INC/IL 3,678,626$9,822,0000.37%
EcoR1 Capital, LLC 3,579,377$9,557,0000.36%
Orbimed Advisors 8,053,298$21,502,0000.22%
Stonepine Capital Management, LLC 46,886$125,0000.06%
Ikarian Capital, LLC 100,000$267,0000.02%
ALGERT GLOBAL LLC 19,737$53,0000.02%
Windsor Creek Advisors, LLC 14,786$39,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders